Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.24.23 (
MMP
)
4,246
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The amount of elastic fibers from lesional and healthy skin areas of five patients with
anetoderma
was determined by automated image analysis. Dermal elastic fibers were almost completely absent in anetodermic skin and preelastic fibers were undetectable or extremely rare. Organ cultures were performed using explants from affected and unaffected skin areas of the same patient. We identified and quantified proteases in the culture media of explants: MMP-1 (collagenase 1), MMP-2 and MMP-9 (gelatinases A and B), MMP-3 (stromelysin 1), MMP-7 (
matrilysin
1), and tissue inhibitors of metalloproteinases, TIMP-1 and TIMP-2. The data were compared with those of two healthy donors. For the five samples of anetodermic skin, MMP-1 levels were significantly higher compared with the uninvolved cultures and the two healthy samples. A significant increase of TIMP-1 expression was also observed in the affected cultures. We demonstrated a significant increase in the production of gelatinase A in lesional skin when compared with nonlesional skin and healthy donor samples. We found no significant production of TIMP-2 in the five samples of anetodermic skin compared with the samples from the two healthy donors. There was a significant decrease in TIMP-2 expression in the five nonlesional samples compared with the control samples. These data are in favor of an altered balance in anetodermic patients between MMP-2 and TIMP-2. Levels of MMP-9, MMP-3, and MMP-7 were significantly higher in the culture-conditioned media of the anetodermic skin samples than the nonlesional skin cultures. Because MMP-3, MMP-7, MMP-9 are known to degrade elastin, and MMP-3 can activate the latent forms of MMP-7 and MMP-9, we propose that these metalloproteinases also participate in the degradation of elastic fibers in anetodermic skin.
...
PMID:Anetoderma: an altered balance between metalloproteinases and tissue inhibitors of metalloproteinases. 1197 71
Background
. The clinical and histopathologic classification of
anetoderma
are not well characterized.
Objective
. We aimed to investigate the clinical and histopathologic characteristics of
anetoderma
and to correlate clinical phenotypes with immunohistopathologic findings.
Methods
. We retrospectively reviewed the medical records of 30 patients with
anetoderma
and performed immunohistochemistry for elastin, fibrillin-1, metalloproteinase- (
MMP
-) 2, MMP-7, MMP-9, and MMP-12, and tissue inhibitor of metalloproteinase- (TIMP-) 1 and TIMP-2.
Results
. Protruding type (
n
= 17) had a longer disease duration and more severe loss of elastin, without changes in fibrillin, than indented type (
n
= 13). MMP-2 and MMP-9 showed significantly higher expressions in the dermis compared with controls (
p
< 0.05). MMP-7 and MMP-12 showed little expressions in both
anetoderma
and control tissue. TIMP-1 was highly expressed in
anetoderma
lesions and controls. TIMP-2 expression was variable.
Conclusions
. Our findings suggest that protruding type
anetoderma
may represent a more advanced stage and that MMP-2 and MMP-9 could be responsible for elastic fiber degradation in
anetoderma
.
...
PMID:A Clinicoimmunohistopathologic Study of Anetoderma: Is Protruding Type More Advanced in Stage Than Indented Type? 2811 17